Azenta (AZTA) revenue breakdown
By segment, Multiomics is the largest at 45% of fiscal 2025 revenue; Sample Repository Solutions grew fastest, 6% a year over 3 years.
By product, Service is the largest at 71% of fiscal 2025 revenue, growing 17% a year over 8 years.
Revenue by segment
Fiscal years, as Azenta reports them in its 10-K filings; fiscal 2025 total $594M.
| Segments | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Multiomics | — | — | — | — | — | — | $251M | $248M | $255M | $269M | 45% |
| Core Products | — | — | — | — | — | — | $199M | $192M | $197M | $198M | 33% |
| Sample Repository Solutions | — | — | — | — | — | — | $105M | $111M | $122M | $127M | 21% |
| Brooks Semiconductor Solutions Group | $37M | $379M | $435M | — | — | — | — | — | — | — | — |
| Life Sciences Services | — | — | $90M | $215M | $259M | $314M | — | — | — | — | — |
| Life Sciences Products | — | — | $106M | $119M | $130M | $200M | — | — | — | — | — |
| Brooks Life Sciences | $62M | $149M | — | — | — | — | — | — | — | — | — |
Revenue by product
Fiscal years, as Azenta reports them in its 10-K filings; fiscal 2025 total $594M.
| Products | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| Service | $121M | $149M | $234M | $278M | $333M | $375M | $375M | $400M | $421M | 71% |
| Product | $407M | $482M | $100M | $111M | $181M | $181M | $176M | $174M | $173M | 29% |
Revenue by region
Fiscal years, as Azenta reports them in its 10-K filings; fiscal 2025 total $594M.
| Regions | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| UNITED STATES | — | — | — | — | — | — | $358M | $351M | $365M | $365M | 61% |
| Europe | — | — | $136M | $60M | $74M | $77M | $79M | $87M | $95M | $107M | 18% |
| CHINA | — | — | — | — | $34M | $46M | $54M | $52M | $58M | $58M | 10% |
| UNITED KINGDOM | — | — | — | — | — | $32M | $30M | $27M | $27M | $35M | 6% |
| Asia Pacific | $196M | $256M | $263M | $48M | $24M | $34M | $33M | $26M | $21M | $23M | 4% |
| Other | — | — | — | — | — | — | — | $8M | $6M | $4M | 1% |
| North America | $157M | $174M | $233M | $226M | $256M | $324M | — | — | — | — | — |
| Rest of Europe | $49M | $60M | — | — | — | — | — | — | — | — | — |
| United Kingdom | $31M | $37M | — | — | — | — | — | — | — | — | — |
| Africa | — | — | — | — | — | $688,000 | $1M | — | — | — | — |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for AZTA.
Open AZTA in InvestinglyQuestions
Where does Azenta make its money?
In fiscal 2025, by segment: Multiomics $269M, Core Products $198M, Sample Repository Solutions $127M.
From Azenta's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.